Hepatitis/Liver Disease Flashcards
Hep A is chronic or acute?
acute
Transmission of HAV
fecal-oral
- improper handwashing
- contaminated food/water
HAV symptoms are usually ____ and ____
mild and non-specific
HBV and HCV are usually acute or chronic
BOTH!
acute illness that can lead to chronic infection, cirrhosis, cancer, liver failure, and death
HBV/HCV transmission
infectious blood or body fluids
Which hepatitis does NOT have a vaccine?
HCV
HAV first line tx
supportive
HBV first line tx
PEG-INF or NRTI (tenofovir or entecavir)
HCV first line treatment naive
DAA (direct acting antivirals) combination
How many HCV genotypes are there?
6
What three things determine HCV therapy?
- genotype
- presence of cirrhosis
- treatment naive?
What is a prefered HCV regimen?
2-3 DAAs with different mechanisms
What is the prefered duration of HCV treatment?
8-12 weeks
Ritonavir role in HCV treatment
dose not have action against HCV itself, but used to boost levels of HV protease inhibitors
Interferon’s role in HCV
no recommended in combination therapy can be considered if DAAs are CI or too expensive
Treatment options for treatment-naive patients without cirrhosis
glecaprevir/pibrentasvir
sofosbuvir/velpatasvir
Three types of DAA mechanisms
- NS3/4A Protease inhibitor
- NS5A Replication Complex Inhibitor
- NS5B Polymerase Inhibitor
list of Ns3/4A PIs
"-previr" P for PI glecaprevir grazoprevir paritaprevir voxilaprevir
list of NS5A replication complex inhibitors
"-asvir" A for NS5A ledipasvir ombitasvir pibrentasvir velpatasvir
list of NS5B Polymerase inhibitors
“-buvir” B for NS5B
dasabuvir
sofosbuvir
Protease Inhibitors should be taken with or without food?
with food! PIG (PIs and Grub)
What do patients need to be tested for before starting a DAA
HBV - risk of reactivating
Sofosbuvir specific warnings
- do not take with amiodarone -> serious symptomatic bradycardia possilbe
- risk of hypoglycemia when used with insulin
Side effects of DAAs
typically well tolerated
- HA, fatigue, diarrhea, nausea
What to monitor with DAAS
LFTs (bilirubin)
HCV-RNA
Sovaldi
Sofosbuvir
400mg daily
*dispense in original packaging
Epclusa
Sofosbuvir/velpatasvir
1 tablet daily
*dispense in original packaging
avoid acid-suppressive therapy
Harvoni
sofosbuvir/ledipasvir
1 tablet daily
*dispense in original packaging
avoid acid-suppressive therapy
Vosevi
sofosbuvir/velpatasvir/voxilaprevir
*dispense in original packaging
avoid acid-suppressive therapy
Mavyret
glecaprevir/pibrentasvir
3 tablets daily
*Take with food (glecaprevir)
CI: mod-severe hepatic impairment or decompensation
Technivie
paritaprevir/ritonavir/ombitasvir
*take with food (paritaprevir)
Viekira Pak
paritaprevir/ritonavir/ombitasvir+ dasabuvir
Tri - 2 tablets in the morning
dasabubvir - twice daily with meals